ConductScience.org, home

Paper17547871

Asymptomatic bacterial vaginosis: is it time to treat?

Gibbs RS. Am J Obstet Gynecol, 2007. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Asymptomatic bacterial vaginosis: is it time to treat? Papers, record 17547871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17547871

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Asymptomatic bacterial vaginosis: is it time to treat?
PubMed
Journal
Am J Obstet Gynecol
PubMed
Year
2007
PubMed
Publication types
Comment, Editorial
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2013-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gibbs RSRonald S

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
MetronidazoleMajor topic
Randomized Controlled Trials as TopicMajor topic
Vaginosis, BacterialMajor topic
Chlamydia Infections
Female
Gonorrhea
Humans

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on17547876A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases.https://conductscience.org/library/papers/17547876

Source PubMed

Download CSV of comments and corrections

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
41353361VIRGO2: an enhanced gene catalog of the vaginal microbiome provides insights into its functional and ecology complexity.Nat Commun2025https://conductscience.org/library/papers/41353361PubMed
40113887Probiotics reduce the recurrence of asymptomatic bacterial vaginosis in Chinese women.Sci Rep2025https://conductscience.org/library/papers/40113887PubMed
34136097In silico trio-biomarkers for bacterial vaginosis revealed by species dominance network analysis.Comput Struct Biotechnol J2021https://conductscience.org/library/papers/34136097PubMed
33814990Asymptomatic Bacterial Vaginosis: To Treat or Not to Treat?Curr Infect Dis Rep2020https://conductscience.org/library/papers/33814990PubMed
33572162Understanding Human Microbiota Offers Novel and Promising Therapeutic Options against Candida Infections.Pathogens2021https://conductscience.org/library/papers/33572162PubMed
33316918Distinct Functional Traits of Lactobacilli from Women with Asymptomatic Bacterial Vaginosis and Normal Microbiota.Microorganisms2020https://conductscience.org/library/papers/33316918PubMed
31901667Bacterial vaginosis-A brief synopsis of the literature.Eur J Obstet Gynecol Reprod Biol2020https://conductscience.org/library/papers/31901667PubMed
26210791BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.Trials2015https://conductscience.org/library/papers/26210791PubMed
24484853The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women.Microbiome2014https://conductscience.org/library/papers/24484853PubMed
22900080Resolution and characterization of distinct cpn60-based subgroups of Gardnerella vaginalis in the vaginal microbiota.PLoS One2012https://conductscience.org/library/papers/22900080PubMed
22252803
The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli.
Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22252803PubMed
21949544Elucidation of the Molecular Mechanisms of Action of the Natural Antimicrobial Peptide Subtilosin Against the Bacterial Vaginosis-associated Pathogen Gardnerella vaginalis.Probiotics Antimicrob Proteins2011https://conductscience.org/library/papers/21949544PubMed
18923673Spermicidal activity of the safe natural antimicrobial peptide subtilosin.Infect Dis Obstet Gynecol2008https://conductscience.org/library/papers/18923673PubMed
18762999Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study.Eur J Clin Microbiol Infect Dis2009https://conductscience.org/library/papers/18762999PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17547871

GET https://conductscience.org/api/papers/v1/17547871/authors